LIAISON® RUBELLA IGG II - COFEPRIS Registration 65R2019 SSA
Access comprehensive regulatory information for LIAISON® RUBELLA IGG II (LIAISON® RUBELLA IGG II) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 65R2019 SSA and manufactured by DIASORIN MÉXICO S.A. DE C.V.. The device was registered on January 25, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO LIAISON® RUBELLA IGG II EMPLEA LA TECNOLOGÍA DE LA QUIMIOLUMINISCENCIA (CLIA) EN UN ENSAYO INMUNOLÓGICO PARA LA DETERMINACIÓN CUANTITATIVA Y LA DETECCIÓN CUALITATIVA DE ANTICUERPOS IGG ESPECÍFICOS CONTRA EL VIRUS DE LA RUBEOLA EN MUESTRAS DE SUE
THE LIAISON® RUBELLA IGG II ASSAY EMPLOYS CHEMILUMINESCENCE TECHNOLOGY (CLIA) IN AN IMMUNOLOGICAL ASSAY FOR THE QUANTITATIVE DETERMINATION AND QUALITATIVE DETECTION OF RUBELLA VIRUS-SPECIFIC IGG ANTIBODIES IN SUE SAMPLES.